[Effects of barbexaclone in Lennox-Gastaut syndrome].
The Lennox-Gastaut syndrome has been a source of interest for many workers both from a clinical and electroencephalographic view point. Treatment has always posed problems. Without suggesting an ideal medication for this syndrome, the authors have obtained good results with barbexaclone. Taking into consideration the convulsive manifestations, psychic changes and electroencephalographic details as parameters the therapeutic efficacy of this drug was studied in seven cases.
D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010634:Phenobarbital / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011437:Propylamines / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use
D000927:Anticonvulsants; D011437:Propylamines; C011019:barbexaclone; D010634:Phenobarbital
Efeitos do barbexaclone na síndrome de Lennox-Gastaut.